Several of these elements that are modified in the serum, or in the BM, of MM patients have proinflammatory actions, such as IL-1, IL-6, IL-12, IL-15, IL-16, IL-17, IL-18, IL-22, IL-23, TNF-α, and IFN-γ, while others have anti-inflammatory actions, such as IL-1Rα, IL-4, IL-10, IL-11, TGF-β1, heat shock proteins (HSPs), and lipoxin A4. This evidence concerns the gene IL1B and Miyoshi myopathy.